YOLFTbeta
PZ Cormay SA

PZ Cormay SA

CRM · WAR · Technology / Scientific & Technical Instruments

0.486PLN+0.01 (+1.46%)

Price History

Full chart

Market Stats

Previous Close0.479
Open0.47
Day Range0.47 – 0.489
52-Week Range0.338 – 0.89
Volume23.24K
Market Cap43.79M
P/E (TTM)0.00
Forward P/E0.00
EPS-0.08
Dividend Yield0.00%
Beta-0.08
50-Day Avg0.5321
200-Day Avg0.5121

About

PZ Cormay S.A., a diagnostic company, provides IVD solutions in Poland and internationally. The company offers analyzers, reagents, cleaning liquids, calibrators, control materials, patterns, and agglutination tests. It also provides analyzers, test strips, inspections, and calibration strips. In addition, the company offers parasitology, such as Paragreen Mini-System, a specialized device for concentrating and preserving stool samples, as well as veterinary medicines. Further, it provides immunochemistry, including SNIBE, MINDRAY, and DIESSE, as well as molecular biology, such as RT-PCR systems, systems for isolating genetic material, workstations, RT-PCR reagent kits, and nucleic acid isolation reagent kits. Additionally, the company offers sampling comprising blood and urine samples and supporting materials, as well as Sentimag systems, Magtrace markers, Magseed Markers, and surgical instruments, as well as HPLC systems, point of care diagnostics, and integrated systems. The company was founded in 1985 and is based in Lomianki, Poland.

Company Details

  • SectorTechnology
  • IndustryScientific & Technical Instruments
  • CEOMr. Flavio Finotello
  • Employees220
  • Headquartersul. Wiosenna 22, Lomianki, Poland, 05-092, Poland
  • Websitehttps://cormay.com

Leadership

  • Mr. Flavio FinotelloPresident of the Management Board
  • Mr. Wojciech SuchowskiVice President of the Management Board

Financials

Income Statement

Currency: PLN2008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue31.09M38.45M61.94M90.03M105.47M100.80M100.11M45.00M82.28M77.58M69.79M68.41M65.29M84.73M85.36M82.22M91.62M96.31M
Growth (%)-+23.70%+61.09%+45.35%+17.16%-4.43%-0.68%-55.05%+82.82%-5.70%-10.04%-1.98%-4.56%+29.78%+0.74%-3.67%+11.43%+5.11%
Cost of Revenue19.41M22.61M35.63M71.38M61.08M58.02M57.24M33.73M51.01M46.44M41.71M41.47M38.78M52.47M50.49M48.62M58.06M58.38M
Gross Profit11.67M15.84M26.31M18.65M44.39M42.78M42.87M11.27M31.26M31.14M28.08M26.94M26.51M34.54M34.88M33.60M33.56M37.92M
Gross Margin37.54%41.19%42.48%20.72%42.09%42.44%42.82%25.05%38.00%40.14%40.24%39.39%40.60%40.76%40.86%40.87%36.63%39.38%
Operating Expense9.84M12.63M21.21M5.88M30.66M34.15M87.08M20.86M39.06M39.86M55.43M69.74M33.81M34.60M39.19M38.91M38.51M41.40M
Operating Income1.83M3.21M5.10M12.77M13.74M8.63M-44.21M-9.59M-7.79M-8.71M-27.35M-42.80M-7.30M-68.00K-4.31M-5.30M-4.96M-3.48M
Operating Margin5.88%8.35%8.23%14.18%13.02%8.56%-44.16%-21.31%-9.47%-11.23%-39.19%-62.56%-11.19%-0.08%-5.05%-6.45%-5.41%-3.61%
EBITDA2.87M4.73M6.47M15.52M17.48M12.75M-54.83M-20.27M-11.15M445.00K-23.01M-35.99M-8.01M6.53M-1.21M2.13M1.07M2.52M
EBITDA Margin9.23%12.30%10.45%17.23%16.57%12.65%-54.77%-45.04%-13.56%0.57%-32.97%-52.61%-12.27%7.71%-1.42%2.59%1.16%2.62%
Net Income1.42M2.96M6.13M14.01M15.38M6.85M-47.36M-5.16M-10.99M-2.02M-24.98M-40.97M-12.66M1.64M-6.96M-4.53M-5.27M-4.16M
Net Income Margin4.57%7.69%9.90%15.56%14.58%6.80%-47.30%-11.46%-13.36%-2.60%-35.79%-59.89%-19.40%1.93%-8.16%-5.51%-5.75%-4.32%
R&D-----5.43M2.27M124.00K254.00K5.99M19.63M45.48M2.76M3.23M3.46M4.08M4.08M3.16M
R&D as % of Total Revenue-----5.39%2.27%0.28%0.31%7.72%28.12%66.48%4.23%3.81%4.05%4.96%4.45%3.28%
Interest Expense78.00K251.00K1.09M716.00K1.73M740.00K1.71M602.00K334.00K244.00K316.00K718.00K338.00K419.00K644.00K900.00K862.00K937.00K
Interest Expense % of Total Revenue0.25%0.65%1.76%0.80%1.64%0.73%1.71%1.34%0.41%0.31%0.45%1.05%0.52%0.49%0.75%1.09%0.94%0.97%

Balance Sheet

Currency: PLN2008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets27.83M50.75M85.06M159.66M248.00M296.52M254.02M227.14M188.21M174.55M161.50M102.47M93.74M99.69M101.97M93.90M89.72M88.25M
Total Liabilities8.87M7.95M18.61M52.30M55.54M68.53M67.29M53.00M43.39M38.86M42.80M28.66M30.42M33.98M40.22M38.23M39.72M41.21M
Total Equity18.95M42.81M66.45M108.21M172.53M171.29M98.39M125.94M102.02M128.89M111.73M72.16M62.44M64.85M61.26M55.26M49.56M45.93M
Cash5.51M20.89M25.28M31.26M95.62M53.73M53.09M24.00M3.33M2.15M2.35M7.26M9.74M2.51M1.29M3.83M3.24M4.65M
Total Debt1.74M920.00K4.84M15.18M19.40M10.26M24.75M7.88M621.00K3.03M3.38M2.13M4.64M4.09M4.07M4.91M5.96M10.24M
Net Debt-3.78M-19.97M-20.44M-16.08M-76.22M-43.47M-28.34M-16.13M-2.71M876.00K1.03M-5.13M-5.09M1.58M2.78M1.08M2.72M5.59M

Cash Flow

Currency: PLN2008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow2.20M-1.58M-9.75M2.33M2.25M-17.45M7.93M-5.27M-5.17M1.66M-1.56M-4.39M-161.00K-1.47M-8.71M-3.25M-2.63M-699.00K
Investing Cash Flow-960.00K-3.22M-9.04M-35.04M-5.50M-74.76M-25.86M-10.44M-14.79M-3.82M-4.19M19.37M154.00K-4.72M8.97M5.52M3.40M-1.22M
Financing Cash Flow3.21M20.18M23.17M38.69M67.61M50.32M17.29M35.49M-724.00K792.00K6.90M-8.72M2.13M-619.00K-1.34M-19.00K-1.21M3.22M
Capital Expenditure1.96M2.10M4.28M15.10M6.59M3.23M6.72M5.39M5.03M8.13M6.90M11.15M4.66M6.75M8.44M3.66M703.00K1.45M
Free Cash Flow248.00K-3.68M-14.02M-12.77M-4.34M-20.68M1.21M-10.66M-10.20M-6.47M-8.46M-15.54M-4.82M-8.21M-17.14M-3.48M-3.96M-2.15M
Dividends Paid---------178.00K178.00K178.00K178.00K279.00K5.00K-203.00K-
FCF to OCF11.26%232.81%143.87%-547.04%-192.41%118.51%15.25%202.20%197.37%-390.70%541.90%353.99%2996.27%559.22%196.85%107.17%150.59%307.44%
Dividend Paid to FCF----------2.75%-2.10%-1.15%-3.69%-3.40%-0.03%--5.13%-

Earnings

Report DateMar 31, 2009Jun 30, 2009Sep 30, 2009Dec 31, 2009Mar 31, 2010Jun 30, 2010Sep 30, 2010Dec 31, 2010Mar 31, 2011Jun 30, 2011Sep 30, 2011Dec 31, 2011Mar 31, 2012Jun 30, 2012Sep 30, 2012Dec 31, 2012Mar 31, 2013Jun 30, 2013Sep 30, 2013Dec 31, 2013Mar 31, 2014Jun 30, 2014Sep 30, 2014Dec 31, 2014Mar 31, 2015Aug 31, 2015Nov 16, 2015May 16, 2016Sep 1, 2016Nov 15, 2016Mar 17, 2017May 15, 2017Aug 31, 2017Nov 14, 2017Dec 31, 2017May 15, 2018Aug 17, 2018Nov 14, 2018Dec 31, 2018Apr 13, 2019Jun 30, 2019Sep 30, 2019Dec 31, 2019Mar 31, 2020Jun 30, 2020Sep 30, 2020Dec 31, 2020Mar 31, 2021Jun 30, 2021Sep 30, 2021Dec 31, 2021Mar 31, 2022Jun 30, 2022Sep 30, 2022Dec 31, 2022Mar 31, 2023Jun 30, 2023Sep 30, 2023Dec 31, 2023Mar 31, 2024Jun 30, 2024Sep 30, 2024Dec 31, 2024Mar 31, 2025Jun 30, 2025Sep 30, 2025Dec 31, 2025Mar 31, 2026Jun 30, 2026
EPS Estimate---------------------------------------------------------------------
EPS Actual0.050.050.060.020.050.060.070.020.080.060.140.080.130.040.140.050.110.070.060.060.06-0.260.03-0.160.07-0.06-0.040.02-0.00-0.02-0.17-0.01-0.01-0.020.01-0.00-0.00-0.02-0.300.03-0.04-0.03-0.44-0.090.01-0.02-0.050.010.02-0.030.02-0.03-0.040.01-0.010.02-0.02-0.04-0.01-0.00-0.04-0.020.000.01-0.03-0.01-0.02-0.03-0.00
Surprise---------------------------------------------------------------------
Timing-------------------------After-hoursPre-marketAfter-hoursPre-marketPre-marketPre-marketAfter-hoursAfter-hoursAfter-hours-After-hoursAfter-hoursAfter-hours-Pre-market-----------------------------

Key Statistics & Ratios

Market Cap43.79M
Enterprise Value54.18M
Trailing P/E0.00
Forward P/E0.00
Price / Sales0.43
Price / Book1.01
EPS-0.08
Book Value0.524
Revenue (TTM)101.14M
Gross Profit (TTM)39.49M
EBITDA1.65M
Profit Margin-4.54%
Operating Margin1.45%
Return on Equity-9.83%
Return on Assets-1.59%
Shares Outstanding84.21M
Shares Float70.16M
Beta-0.08
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Stock Splits

  • Jun 11, 201529:22